Dermatologic Manifestations of Pulmonary Disease: Multimedia

References

1. Adams, F, translator. The genuine works of Hippocrates. New York, NY: Wm Wood & Co; 1891.

2. Dickinson CJ, Martin JF. Megakaryocytes and platelet clumps as the cause of finger clubbing. Lancet. Dec 19 1987;2(8573):1434-5. [Medline].

3. Martinez-Lavin M. Exploring the cause of the most ancient clinical sign of medicine: finger clubbing. Semin Arthritis Rheum. Jun 2007;36(6):380-5. [Medline].

4. Spicknall KE, Zirwas MJ, English JC 3rd. Clubbing: an update on diagnosis, differential diagnosis, pathophysiology, and clinical relevance. J Am Acad Dermatol. Jun 2005;52(6):1020-8. [Medline].

5. Schamroth L. Personal experience. S Afr Med J. Feb 28 1976;50(9):297-300. [Medline].

6. Myers KA, Farquhar DR. The rational clinical examination. Does this patient have clubbing?. JAMA. Jul 18 2001;286(3):341-7. [Medline].

7. Lovibond JL. Diagnosis of clubbed fingers. Lancet. 1938;363-4.

8. Stavem P. Instrument for estimation of clubbing. Lancet. Jul 4 1959;2(7088):7-8. [Medline].

9. Dreizen S, Dhingra HM, Chiuten DF, Umsawasdi T, Valdivieso M. Cutaneous and subcutaneous metastases of lung cancer. Clinical characteristics. Postgrad Med. Dec 1986;80(8):111-6. [Medline].

10. Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol. Aug 1993;29(2 Pt 1):228-36. [Medline].

11. Lookingbill DP, Spangler N, Sexton FM. Skin involvement as the presenting sign of internal carcinoma. A retrospective study of 7316 cancer patients. J Am Acad Dermatol. Jan 1990;22(1):19-26. [Medline].

12. Matucci-Cerinic M, Lotti T, Jajic I, Pignone A, Bussani C, Cagnoni M. The clinical spectrum of pachydermoperiostosis (primary hypertrophic osteoarthropathy). Medicine (Baltimore). May 1991;70(3):208-14. [Medline].

13. Segal AM, Mackenzie AH. Hypertrophic osteoarthropathy: a 10-year retrospective analysis. Semin Arthritis Rheum. Nov 1982;12(2):220-32. [Medline].

14. Schumacher HR Jr. Articular manifestations of hypertrophic pulmonary osteoarthropathy in bronchogenic carcinoma. Arthritis Rheum. May-Jun 1976;19(3):629-36. [Medline].

15. Stenseth JH, Clagett OT, Woolner LB. Hypertrophic pulmonary osteoarthropathy. Dis Chest. Jul 1967;52(1):62-8. [Medline].

16. Yacoub MH. Relation between the histology of bronchial carcinoma and hypertrophic pulmonary osteoarthropathy. Thorax. 1965;20:537-9.

17. Hirschmann JV, Raugi GJ. Dermatologic features of the superior vena cava syndrome. Arch Dermatol. Jul 1992;128(7):953-6. [Medline].

18. Schraufnagel DE, Hill R, Leech JA, Pare JA. Superior vena caval obstruction. Is it a medical emergency?. Am J Med. Jun 1981;70(6):1169-74. [Medline].

19. Loeffler JS, Leopold KA, Recht A, Weinstein HJ, Tarbell NJ. Emergency prebiopsy radiation for mediastinal masses: impact on subsequent pathologic diagnosis and outcome. J Clin Oncol. May 1986;4(5):716-21. [Medline].

20. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. Apr 24 1997;336(17):1224-34. [Medline].

21. Winterbauer RH, Belic N, Moores KD. Clinical interpretation of bilateral hilar adenopathy. Ann Intern Med. Jan 1973;78(1):65-71. [Medline].

22. Kerdel FA, Moschella SL. Sarcoidosis. An updated review. J Am Acad Dermatol. Jul 1984;11(1):1-19. [Medline].

23. Wilson NJ, King CM. Cutaneous sarcoidosis. Postgrad Med J. Nov 1998;74(877):649-52. [Medline].

24. Mañá J, Marcoval J, Graells J, Salazar A, Peyrí J, Pujol R. Cutaneous involvement in sarcoidosis. Relationship to systemic disease. Arch Dermatol. Jul 1997;133(7):882-8. [Medline].

25. Cribier B, Caille A, Heid E, Grosshans E. Erythema nodosum and associated diseases. A study of 129 cases. Int J Dermatol. Sep 1998;37(9):667-72. [Medline].

26. Daoud MS, Gibson LE, DeRemee RA, Specks U, el-Azhary RA, Su WP. Cutaneous Wegener's granulomatosis: clinical, histopathologic, and immunopathologic features of thirty patients. J Am Acad Dermatol. Oct 1994;31(4):605-12. [Medline].

27. Frances C, Du LT, Piette JC, et al. Wegener's granulomatosis. Dermatological manifestations in 75 cases with clinicopathologic correlation. Arch Dermatol. Jul 1994;130(7):861-7. [Medline].

28. Patten SF, Tomecki KJ. Wegener's granulomatosis: cutaneous and oral mucosal disease. J Am Acad Dermatol. May 1993;28(5 Pt 1):710-8. [Medline].

29. Duna GF, Galperin C, Hoffman GS. Wegener's granulomatosis. Rheum Dis Clin North Am. Nov 1995;21(4):949-86. [Medline].

30. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. Jan 1983;98(1):76-85. [Medline].

31. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. Mar 15 1992;116(6):488-98. [Medline].

32. Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med. Jul 1 2004;117(1):39-50. [Medline].

33. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore). Jan 1999;78(1):26-37. [Medline].

34. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore). Mar 1984;63(2):65-81. [Medline].

35. Choi YH, Im JG, Han BK, Kim JH, Lee KY, Myoung NH. Thoracic manifestation of Churg-Strauss syndrome: radiologic and clinical findings. Chest. Jan 2000;117(1):117-24. [Medline].

36. Schwartz RA, Churg J. Churg-Strauss syndrome. Br J Dermatol. Sep 1992;127(3):199-204. [Medline].

37. Michet CJ Jr, McKenna CH, Luthra HS, O'Fallon WM. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med. Jan 1986;104(1):74-8. [Medline].

38. Trentham DE, Le CH. Relapsing polychondritis. Ann Intern Med. Jul 15 1998;129(2):114-22. [Medline].

39. Eng J, Sabanathan S. Airway complications in relapsing polychondritis. Ann Thorac Surg. Apr 1991;51(4):686-92. [Medline].

40. Dunne JA, Sabanathan S. Use of metallic stents in relapsing polychondritis. Chest. Mar 1994;105(3):864-7. [Medline].

41. Gossage JR, Kanj G. Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med. Aug 1998;158(2):643-61. [Medline].

42. Sabbà C. A rare and misdiagnosed bleeding disorder: hereditary hemorrhagic telangiectasia. J Thromb Haemost. Oct 2005;3(10):2201-10. [Medline].

43. Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med. Oct 5 1995;333(14):918-24. [Medline].

44. Stoller JK. Clinical features and natural history of severe alpha 1-antitrypsin deficiency. Roger S. Mitchell Lecture. Chest. Jun 1997;111(6 Suppl):123S-128S. [Medline].

45. Hendrick SJ, Silverman AK, Solomon AR, Headington JT. Alpha 1-antitrypsin deficiency associated with panniculitis. J Am Acad Dermatol. Apr 1988;18(4 Pt 1):684-92. [Medline].

46. Smith KC, Pittelkow MR, Su WP. Panniculitis associated with severe alpha 1-antitrypsin deficiency. Treatment and review of the literature. Arch Dermatol. Dec 1987;123(12):1655-61. [Medline].

47. Kaplan RP, Grant JN, Kaufman AJ. Dermatologic features of the fat embolism syndrome. Cutis. Jul 1986;38(1):52-5. [Medline].

48. Mellor A, Soni N. Fat embolism. Anaesthesia. Feb 2001;56(2):145-54. [Medline].

49. Samman PD, White WF. The "Yellow Nail" Syndrome. Br J Dermatol. Apr 1964;76:153-7. [Medline].

50. Bull RH, Fenton DA, Mortimer PS. Lymphatic function in the yellow nail syndrome. Br J Dermatol. Feb 1996;134(2):307-12. [Medline].

Further Reading

1. Abner A. Approach to the patient who presents with superior vena cava obstruction. Chest. Apr 1993;103(4 Suppl):394S-397S. [Medline].
2. Abril A, Calamia KT, Cohen MD. The Churg Strauss syndrome (allergic granulomatous angiitis): review and update. Semin Arthritis Rheum. Oct 2003;33(2):106-14. [Medline].
3. Beer DJ, Pereira W Jr, Snider GL. Pleural effusion associated with primary lymphedema: a perspective on the yellow nail syndrome. Am Rev Respir Dis. Mar 1978;117(3):595-9. [Medline].
4. Benedek TG. Paraneoplastic digital clubbing and hypertrophic osteoarthropathy. Clin Dermatol. Jan-Mar 1993;11(1):53-9. [Medline].
5. Bentley D, Moore A, Shwachman H. Finger Clubbing: A quantitative survey by analysis of the shadowgraph. Lancet. Jul 24 1976;2(7978):164-7. [Medline].
6. Bird RM, Hammarsten JF, Marshall RA, Robinson RR. A family reunion: a study of hereditary hemorrhagic telangiectasia. N Engl J Med. Jul 18 1957;257(3):105-9. [Medline].
7. Bulger EM, Smith DG, Maier RV, Jurkovich GJ. Fat embolism syndrome. A 10-year review. Arch Surg. Apr 1997;132(4):435-9. [Medline].
8. Burrows NP, Lockwood CM. Antineutrophil cytoplasmic antibodies and their relevance to the dermatologist. Br J Dermatol. Feb 1995;132(2):173-81. [Medline].
9. Cordier JF, Valeyre D, Guillevin L, Loire R, Brechot JM. Pulmonary Wegener's granulomatosis. A clinical and imaging study of 77 cases. Chest. Apr 1990;97(4):906-12. [Medline].
10. Cox CE, Davis-Allen A, Judson MA. Sarcoidosis. Med Clin North Am. Jul 2005;89(4):817-28. [Medline].
11. Currie AE, Gallagher PJ. The pathology of clubbing: vascular changes in the nail bed. Br J Dis Chest. Oct 1988;82(4):382-5. [Medline].
12. Emerson PA. Yellow nails, lymphoedema, and pleural effusions. Thorax. May 1966;21(3):247-53. [Medline].
13. Fabian TC, Hoots AV, Stanford DS, Patterson CR, Mangiante EC. Fat embolism syndrome: prospective evaluation in 92 fracture patients. Crit Care Med. Jan 1990;18(1):42-6. [Medline].
14. Fincher RM. Superior vena cava syndrome: experience in a teaching hospital. South Med J. Oct 1987;80(10):1243-5. [Medline].
15. Ginsburg, J. Hypertrophic Pulmonary Osteoarthropathy. Postgrad Med J. Nov 1963;39:639-45. [Medline].
16. Greenfield GB, Schorsch HA, Shkolnik A. The various roentgen appearances of pulmonary hypertrophic osteoarthropathy. Am J Roentgenol Radium Ther Nucl Med. Dec 1967;101(4):927-31. [Medline].
17. Hansen-Flaschen J, Nordberg J. Clubbing and hypertrophic osteoarthropathy. Clin Chest Med. Jun 1987;8(2):287-98. [Medline].
18. Hershko A, Hirshberg B, Nahir M, Friedman G. Yellow nail syndrome. Postgrad Med J. Aug 1997;73(862):466-8. [Medline].
19. Kent PD, Michet CJ Jr, Luthra HS. Relapsing polychondritis. Curr Opin Rheumatol. Jan 2004;16(1):56-61. [Medline].
20. Levy D. The fat embolism syndrome. A review. Clin Orthop Relat Res. Dec 1990;(261):281-6. [Medline].
21. Lopez-Majano V, Sobti P. Early diagnosis of pulmonary osteoarthropathy in neoplastic disease. J Nucl Med Allied Sci. Apr-Jun 1984;28(2):69-76. [Medline].
22. Muller C, Rahn BA, Pfister U, Meinig RP. The incidence, pathogenesis, diagnosis, and treatment of fat embolism. Orthop Rev. Feb 1994;23(2):107-17. [Medline].
23. Nordkild P, Kromann-Andersen H, Struve-Christensen E. Yellow nail syndrome--the triad of yellow nails, lymphedema and pleural effusions. A review of the literature and a case report. Acta Med Scand. 1986;219(2):221-7. [Medline].
24. Parish JM, Marschke RF Jr, Dines DE, Lee RE. Etiologic considerations in superior vena cava syndrome. Mayo Clin Proc. Jul 1981;56(7):407-13. [Medline].
25. Parisi DM, Koval K, Egol K. Fat embolism syndrome. Am J Orthop. Sep 2002;31(9):507-12. [Medline].
26. Porteous ME, Burn J, Proctor SJ. Hereditary haemorrhagic telangiectasia: a clinical analysis. J Med Genet. Aug 1992;29(8):527-30. [Medline].
27. Racoceanu SN, Mendlowitz M, Suck AF, Wolf RL, Naftchi NE. Digital capillary blood flow in clubbing. 85 Kr studies in hereditary and acquired cases. Ann Intern Med. Dec 1971;75(6):933-5. [Medline].
28. Ranes J, Stoller JK. A review of alpha-1 antitrypsin deficiency. Semin Respir Crit Care Med. Apr 2005;26(2):154-66. [Medline].
29. Regan GM, Tagg B, Thomson ML. Subjective assessment and objective measurement of finger clubbing. Lancet. Mar 11 1967;1(7489):530-2. [Medline].
30. Reingold IM. Cutaneous metastases from internal carcinoma. Cancer. Feb 1966;19(2):162-8. [Medline].
31. Rosenthall L, Kirsh J. Observations of radionuclide imaging in hypertrophic pulmonary osteoarthropathy. Radiology. Aug 1976;120(2):359-62. [Medline].
32. Sane DC, Vidaillet HJ , Burton CS. Saddle nose, red ears, and fatal airway collapse. Relapsing polychondritis. Chest. Feb 1987;91(2):268-70. [Medline].
33. Serota, ML. Fat embolism syndrome. West J Med. Oct 1984;141(4):501-5. [Medline].
34. Spencer PS, Helm TN. Skin metastases in cancer patients. Cutis. Feb 1987;39(2):119-21. [Medline].
35. Sullivan EJ, Hoffman GS. Pulmonary vasculitis. Clin Chest Med. Dec 1998;19(4):759-76, ix. [Medline].
36. Swanson KL, Prakash UB, Stanson AW. Pulmonary arteriovenous fistulas: Mayo Clinic experience, 1982-1997. Mayo Clin Proc. Jul 1999;74(7):671-80. [Medline].
37. Waring WW, Wilkinson RW, Wiebe RA, Faul BC, Hilman BC. Quantitation of digital clubbing children. Measurements of casts of the index finger. Am Rev Respir Dis. 1971;104(2):166-74. [Medline].
38. Wudel LJ Jr, Nesbitt JC. Superior vena cava syndrome. Curr Treat Options Oncol. Feb 2001;2(1):77-91. [Medline].
39. Yellin A, Rosen A, Reichert N, Lieberman Y. Superior vena cava syndrome. The myth--the facts. Am Rev Respir Dis. May 1990;141(5 Pt 1):1114-8. [Medline].

Keywords

dermatologic manifestations of pulmonary disease skin, cutaneous, pulmonary, cyanosis, clubbing, lung cancer, hypertrophic osteoarthropathy, HOA, primary hypertrophic osteoarthropathy, primary HOA, secondary hypertrophic osteoarthropathy, secondary HOA, superior vena cava syndrome, SVC syndrome, sarcoidosis, papular sarcoidosis, lupus pernio, erythema nodosum, EN, Wegener granulomatosis, Churg-Strauss syndrome, relapsing polychondritis, pulmonary arteriovenous malformations, PAVM, alpha-1 antitrypsin deficiency, fat embolism syndrome, yellow nail syndrome

Contributor Information and Disclosures

Author

Paul B Cornia, MD, Staff physician, Assistant Professor of Medicine, University of Washington, Department of Medicine, Veterans Affairs Puget Sound Health Care System
Disclosure: Nothing to disclose.

Coauthor(s)

Gregory J Raugi, MD, PhD, Professor, Department of Internal Medicine, Division of Dermatology, University of Washington at Seattle; Chief, Dermatology Section, Primary and Specialty Care Service, Veterans Administration Medical Center of Seattle
Gregory J Raugi, MD, PhD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

Medical Editor

Kathleen David-Bajar, MD, Former Consultant to the Army Surgeon General, Department of Dermatology, Brooke Army Medical Center
Kathleen David-Bajar, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Pharmacy Editor

Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University School of Medicine; Consulting Staff, Mountain View Dermatology, PA
Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Association of Military Dermatologists, Texas Dermatological Society, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Jeffrey P Callen, MD, Professor of Medicine, Chief, Division of Dermatology, University of Louisville School of Medicine
Jeffrey P Callen, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and American College of Rheumatology
Disclosure: Amgen Honoraria Consulting; Abbott Honoraria Consulting; Electrical Optical Sciences Honoraria Consulting; Centocor Honoraria Consulting; Medicis Honoraria Consulting; Celgene Honoraria Consulting

CME Editor

Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania
Joel M Gelfand, MD, MSCE is a member of the following medical societies: Society for Investigative Dermatology
Disclosure: AMGEN Consulting fee Consulting; AMGEN Grant/research funds None; Genentech Consulting fee Consulting; Centocor Consulting fee Consulting; Centocor Grant/research funds None; Covance Consulting fee Consulting; Shire  Consulting

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.